Chronic spontaneous urticaria: a condition that is rarely seen but has a significant impact and is very costly
This year’s theme is ‘Take back control’. From confusion to understanding. Because those living with the condition often struggle to make themselves understood
World Urticaria Day is an annual event held on 1 October, dedicated to raising awareness of a condition that affects millions of people worldwide but which is often misunderstood.
This year’s theme is ‘Take back control’. From the itch to understanding. Because those living with chronic urticaria often feel at the mercy of their condition: flare-ups strike without warning, the itching dictates how the night will unfold, and explaining this to those who haven’t experienced it – sometimes even to specialists – is the most exhausting part. Taking back control starts right there: with being able to make yourself understood.
Symptoms of the condition
Intense itching, painful swelling and unpredictable skin rashes that can appear anywhere on the body are the most well-known symptoms and a daily reality for many people suffering from chronic urticaria, an often debilitating skin condition characterised by wheals and frequently accompanied by angioedema (painful swelling). In addition to the visible symptoms, urticaria has a profound impact on quality of life, affecting sleep, work, social activities and emotional wellbeing.
“Chronic spontaneous urticaria is a condition that is rarely seen, but has a significant impact,” explains Elena Radaelli, president of the Arco Association for Urticaria Research and Treatment. “The itching, which is often more intense at night, disrupts sleep. The resulting fatigue affects work, study and personal relationships. Added to this is the unpredictability of the symptoms, which makes it difficult to plan one’s life.”
The profit and loss account
A burden that also has a specific economic cost. An Italian study published in 2026 in *Global & Regional Health Technology Assessment*, to which ARCO contributed, Radaelli adds, “estimates average indirect costs of around 4,200 euros per year per patient, rising to 5,200 euros in the most severe cases”. These costs stem primarily from lost working days and reduced productivity. “Patients,” emphasises ARCO’s president, “also pay around 500 euros a year out of their own pockets for consultations, tests and medicines.”

